How many patents does
U3 Pharma have?
patents
305
families
22
granted
64
applications
241
US
42
EP
39
JP
27
CN
22
WO
18
KR
9
RoW
148
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
U3 Pharma
Top ten assignees appearing on patents
2009 - 2018
| u3 pharma | 201 |
| amgen | 140 |
| daiichi sankyo europe | 38 |
| daiichi sankyo company ltd | 34 |
| dalichi sankyo europe | 1 |
2018
| daiichi sankyo europe | 19 |
| amgen | 17 |
| u3 pharma | 2 |
| dalichi sankyo europe | 1 |
| daiichi sankyo company ltd | 1 |
U3 Pharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| antibodies directed to her-3 and uses thereof | 55 | 2005 |
| material and methods for treating or preventing her-3 associated diseases | 51 | 2009 |
| heparin-binding epidermal growth factor-like growth factor antigen binding proteins | 39 | 2007 |
| axl antibodies | 32 | 2007 |
| humanized axl antibodies | 25 | 2009 |
| anti-her3 antibody-drug conjugate | 18 | 2014 |
| her3 inhibitor for modulating radiosensitivity | 14 | 2012 |
| nucleic acid biomarker and use thereof | 11 | 2013 |
| activated her3 as a marker for predicting therapeutic efficacy | 11 | 2006 |
| protein biomarker and uses thereof | 8 | 2013 |